Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Cinrebafusp alfa by Pieris Pharmaceuticals for Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer): Likelihood of Approval
Cinrebafusp alfa is under clinical development by Pieris Pharmaceuticals and currently in Phase I for Human Epidermal Growth Factor Receptor...
Cinrebafusp alfa by Pieris Pharmaceuticals for Adenocarcinoma Of The Gastroesophageal Junction: Likelihood of Approval
Cinrebafusp alfa is under clinical development by Pieris Pharmaceuticals and currently in Phase I for Adenocarcinoma Of The Gastroesophageal Junction....
Cinrebafusp alfa by Pieris Pharmaceuticals for Gastric Cancer: Likelihood of Approval
Cinrebafusp alfa is under clinical development by Pieris Pharmaceuticals and currently in Phase I for Gastric Cancer. According to GlobalData,...